Drug – bio-affecting and body treating compositions – Inorganic active ingredient containing – Heavy metal or compound thereof
Patent
1992-01-07
1993-08-24
Cintins, Marianne M.
Drug, bio-affecting and body treating compositions
Inorganic active ingredient containing
Heavy metal or compound thereof
424719, A01N 5916, A61K 3324
Patent
active
052386899
ABSTRACT:
This invention relates to the use of Ruthenium Red as an immunosuppressive agent to prevent or significantly reduce graft rejection in organ and bone marrow transplantation. Ruthenium Red can also be used as an immunosuppressant drug for T lymphocyte mediated autoimmune diseases. Furthermore, Ruthenium Red may be useful in alleviating psoriasis.
REFERENCES:
Dornand et al, Biochemical Pharmacology 36 (22) 3929-3936, 1987.
Broekemeier et al, J. Biological Chem 264 (14) 7826-7830, 1989.
Kapus et al., J. of Biological Chemistry, 265 (30): 18063-18066 (1990).
Missiaen et al., Biochimica et Biophysica Acta, 1023:449-454 (1990).
Tsuro et al., Gann, 71: 151-154 (1980).
Dwyer Donard S.
Esenther Kristin
Cintins Marianne M.
Cook Rebecca
Procept Inc.
LandOfFree
Use of ruthenium red as immunosuppressive agents does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of ruthenium red as immunosuppressive agents, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of ruthenium red as immunosuppressive agents will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-827296